These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 6801981

  • 1. Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study.
    Kay CR.
    Am J Obstet Gynecol; 1982 Mar 15; 142(6 Pt 2):762-5. PubMed ID: 6801981
    [Abstract] [Full Text] [Related]

  • 2. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    Wilson ES, Cruickshank J, McMaster M, Weir RJ.
    Br J Obstet Gynaecol; 1984 Dec 15; 91(12):1254-60. PubMed ID: 6440589
    [Abstract] [Full Text] [Related]

  • 3. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V.
    Contracept Fertil Sex (Paris); 1985 Jan 15; 13(1 Suppl):425-30. PubMed ID: 12280210
    [Abstract] [Full Text] [Related]

  • 4. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
    Lipson A, Stoy DB, LaRosa JC, Muesing RA, Cleary PA, Miller VT, Gilbert PR, Stadel B.
    Contraception; 1986 Aug 15; 34(2):121-34. PubMed ID: 3096633
    [Abstract] [Full Text] [Related]

  • 5. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S, Mishell DR, Gray G, Dozono-Takano R, Brenner PF, Eide I, de Quattro V, Shaw ST.
    Am J Obstet Gynecol; 1980 Apr 01; 136(7):920-31. PubMed ID: 6767404
    [Abstract] [Full Text] [Related]

  • 6. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
    Prasad RN, Liew D, Ratnam SS.
    Contraception; 1989 Jan 01; 39(1):21-35. PubMed ID: 2521321
    [Abstract] [Full Text] [Related]

  • 7. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
    Godsland IF, Crook D, Devenport M, Wynn V.
    Contraception; 1995 Sep 01; 52(3):143-9. PubMed ID: 7587185
    [Abstract] [Full Text] [Related]

  • 8. Progestogen-only microdose followed by estrogen-progestogen combination, a new approach to oral contraception.
    Russowsky M, Sartoretto JN.
    Contraception; 1982 Jul 01; 26(1):41-9. PubMed ID: 7128133
    [Abstract] [Full Text] [Related]

  • 9. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW, Chenault CB, de la Peña A, Dozier TS, Kraemer DC.
    Fertil Steril; 1978 Nov 01; 30(5):522-33. PubMed ID: 214353
    [Abstract] [Full Text] [Related]

  • 10. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF, Crook D, Simpson R, Proudler T, Felton C, Lees B, Anyaoku V, Devenport M, Wynn V.
    N Engl J Med; 1990 Nov 15; 323(20):1375-81. PubMed ID: 2146499
    [Abstract] [Full Text] [Related]

  • 11. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.
    Int J Fertil Menopausal Stud; 1994 Nov 15; 39(5):283-91. PubMed ID: 7820162
    [Abstract] [Full Text] [Related]

  • 12. Progestogen effects and their relationship to lipoprotein changes. A report from the Oral Contraception Study of the Royal College of General Practitioners.
    Wingrave SJ.
    Acta Obstet Gynecol Scand Suppl; 1982 Nov 15; 105():33-6. PubMed ID: 6805242
    [Abstract] [Full Text] [Related]

  • 13. The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins.
    Wynn V, Niththyananthan R.
    Am J Obstet Gynecol; 1982 Mar 15; 142(6 Pt 2):766-71. PubMed ID: 6801982
    [Abstract] [Full Text] [Related]

  • 14. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P, Walden C, Knopp R, Hoover J, Wallace R, Heiss G, Rifkind B.
    N Engl J Med; 1983 Apr 14; 308(15):862-7. PubMed ID: 6572785
    [Abstract] [Full Text] [Related]

  • 15. Oral contraceptives and cardiovascular risk. Taking a safe course of action.
    Derman RJ.
    Postgrad Med; 1990 Sep 15; 88(4):119-22. PubMed ID: 2204902
    [Abstract] [Full Text] [Related]

  • 16. Oral contraceptive agents.
    Shearman RP.
    Med J Aust; 1986 Feb 17; 144(4):201-5. PubMed ID: 3945219
    [Abstract] [Full Text] [Related]

  • 17. A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. World Health Organization Task Force on Oral Contraception.
    Contraception; 1980 May 17; 21(5):445-59. PubMed ID: 7428356
    [Abstract] [Full Text] [Related]

  • 18. Effects of two low-dose oral contraceptives on serum lipids and lipoproteins: differential changes in high-density lipoprotein subclasses.
    Krauss RM, Roy S, Mishell DR, Casagrande J, Pike MC.
    Am J Obstet Gynecol; 1983 Feb 15; 145(4):446-52. PubMed ID: 6401927
    [Abstract] [Full Text] [Related]

  • 19. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.
    Spellacy WN.
    Am J Obstet Gynecol; 1982 Mar 15; 142(6 Pt 2):732-4. PubMed ID: 7039318
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.